We would love to hear your thoughts about our site and services, please take our survey here.
The Government website continues to estimate "Primary Completion Data" to be 31 May 2023 - that was 2 weeks yesterday.
This is defined as: The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure.
Clearly we are in a very quiet period - however, that is the best time to BUY
Listen again to the interviews, re-read the RNSs - be confident. I know I am.
Regards,
Current treatment 6 cycles max
AVA6000 potential for 12 - 18 cycles !
That’s crazily good , by anyone’s standards
Off the scale and beyond what we could have hoped for when we first invested !!
This feels highly realistic , and with only a Phase 2 necessary. What’s that actually worth alone - I mean, I know very little but that puts the company around the 2.5 billion mark on its own! That’s 5 times the current share price, so £7.50 a share. Let alone a whole platform to go at! ££££
Possibly not that interesting but the clinical trails website, states the below, so I do think Phase 1a will be finished by 3O June:-
Actual Study Start Date :
July 16, 2021
Estimated Primary Completion Date :
May 31, 2023
Estimated Study Completion Date :
June 30, 2023
I will be very surprised if the RNS doesn’t arrive at 7am on Thursday morning. That is then exactly 6 weeks until Science Day. If we don’t get an RNS this week I’ll be disappointed and surprised, actually. We’ve been told early January and that leaves this week. My money is on Thursday and I see a pleasant rise over the next 2 trading sessions (today and tomorrow). These shares are golden tickets and the market is ready to be set alight. Alastair, step forth my friend and show us the warrior you have become.
I think the chomping strategy is one to take seriously. I might get a t-shirt. “Legendary chomper” #donthatethechomp
love it.
However, I have to say I am more relaxed today than I’ve felt for a long time. I can actually see some decent buying over the festive period - I am sure people will be ‘tipping’ avct to take Q1 by storm and that will result in buying pressure against little selling.
(I’d rather be holding avct than any other aim stock, and of that I’m certain).
I can see the thought process with that, and don’t disagree. However there will several big announcements between Xmas and NYE last year for a number of aim companies which completely dispels this theory…
Yeah you’re right let’s talk nonsense instead that’s copy and pasted from the other boards you work on. I’d wager you’ve never even looked at the company website, let alone digested its content.